Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study

BACKGROUND: Treatment strategies are limited for patients with chemotherapy refractory microsatellite stable (MSS) colorectal cancer. We aim to evaluate the efficacy and safety of immune checkpoint inhibitors (ICIs) combined with regorafenib in this population in routine clinical practice. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kaili, Han, Lu, Wu, Shikai, Qu, Xiujuan, Li, Qin, Zhao, Chuanhua, Zhou, Jing, Jin, Xuan, Wang, Yusheng, Yan, Dong, Cheng, Zhiqiang, Hua, Yuwei, Zhang, Yan, Ge, Yang, Sun, Jinghua, Deng, Wei, Zhao, Lin, Zhao, Yunbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123014/
https://www.ncbi.nlm.nih.gov/pubmed/34689233
http://dx.doi.org/10.1007/s00262-021-03083-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123014/
https://www.ncbi.nlm.nih.gov/pubmed/34689233
http://dx.doi.org/10.1007/s00262-021-03083-3

Ejemplares similares